A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories
Matthew E. Falagas, Konstantinos N. Fragoulis, Ioannis Karydis · 2006
Read A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories by Matthew E. Falagas, Konstantinos N. Fragoulis, Ioannis Karydis (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000011.txt.
Description
Matthew Falagas, Konstantinos Fragoulis, and Ioannis Karydis compared drug prices across medicine in a 2006 PLOS ONE study. New antibiotics draw special worry: bacteria keep evolving resistance, so fresh ones are badly needed, yet firms say developing them pays poorly. The authors asked whether new antibiotics actually cost more than new drugs in other fields.
They set the price of new antibiotics beside drugs from other therapeutic categories, from heart medicine to cancer care. Price gaps, where they exist, feed the debate over why so few antibiotics reach the market. The comparison gives policy makers a factual base for arguments about incentives, patents, and the true cost of staying ahead of resistant germs.
Catalog record
| CREATOR | Matthew E. Falagas, Konstantinos N. Fragoulis, Ioannis Karydis |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000011